Literature DB >> 2469729

Human T cell recognition of polymorphic epitopes from malaria circumsporozoite protein.

A S de Groot1, A H Johnson, W L Maloy, I A Quakyi, E M Riley, A Menon, S M Banks, J A Berzofsky, M F Good.   

Abstract

Lymphocytes obtained from forty individuals living in a malaria endemic area of West Africa were tested for in vitro proliferative responses to peptides representing variant regions of the immunodominant T cell domain of the circumsporozoite protein (amino acids 326 to 345, referred to as Th2R, and 361 to 380, referred to as Th3R) from three distinct strains of Plasmodium falciparum. A total of 83% of the individuals responded to at least one of the six peptides tested, confirming that these epitopes are immunodominant. A much greater number of individuals than expected by chance (32% of the responders to Th2R and 27% of the responders to Th3R) reacted to all three of the variant peptides for that epitope, indicating interdependency of the T cell responses, suggestive of cross-reactivity. Nevertheless, some subjects' T cells were clearly able to distinguish each variant peptide from the others. Using EBV transformed B cells, lymphocytes from 10 of the individuals were HLA typed. In this small group, HLA DRw13 was associated with a positive response to any of the peptides, whereas there was a negative association between DQw3 and response to any of the peptides. These results, although limited by the small sample size, suggest that recognition of T epitopes may be Ir gene linked. Our findings suggest that it may be possible to broaden the immunogenicity of an anti-sporozoite malaria vaccine.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2469729

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Immune responses to sporozoite antigens and their relationship to naturally acquired immunity to malaria.

Authors:  B M Greenwood
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  Evidence implicating MHC genes in the immunological nonresponsiveness to the Plasmodium falciparum CS protein.

Authors:  M F Good; S Kumar; A S De Groot; W R Weiss; I A Quakyi; F Dontfraid; G E Smith; M Cochran; J A Berzofsky; L H Miller
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

3.  Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: relevance for vaccine development.

Authors:  D L Doolan; A J Saul; M F Good
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

4.  Next generation sequencing to detect variation in the Plasmodium falciparum circumsporozoite protein.

Authors:  Kavita Gandhi; Mahamadou A Thera; Drissa Coulibaly; Karim Traoré; Ando B Guindo; Ogobara K Doumbo; Shannon Takala-Harrison; Christopher V Plowe
Journal:  Am J Trop Med Hyg       Date:  2012-05       Impact factor: 2.345

5.  Survival and antigenic profile of irradiated malarial sporozoites in infected liver cells.

Authors:  A Suhrbier; L A Winger; E Castellano; R E Sinden
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

6.  Lymphocyte response in vitro to Plasmodium falciparum merozoite antigens in donors from a holoendemic area.

Authors:  A Dieye; H G Heidrich; C Rogier; J F Trape; P Launois; A A Holder; J L Sarthou
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

Review 7.  Immune Responses in Malaria.

Authors:  Carole A Long; Fidel Zavala
Journal:  Cold Spring Harb Perspect Med       Date:  2017-08-01       Impact factor: 6.915

8.  Use of a tuberculin purified protein derivative--Asn-Ala-Asn-Pro conjugate in bacillus Calmette-Guérin primed mice overcomes H-2 restriction of the antibody response and avoids the need for adjuvants.

Authors:  A R Lussow; G Del Giudice; L Rénia; D Mazier; J P Verhave; A S Verdini; A Pessi; J A Louis; P H Lambert
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

9.  Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy.

Authors:  Magaly Chinchilla; Marcela F Pasetti; Sandra Medina-Moreno; Jin Yuan Wang; Oscar G Gomez-Duarte; Rick Stout; Myron M Levine; James E Galen
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

10.  Variation in the circumsporozoite protein of Plasmodium falciparum: vaccine development implications.

Authors:  Kavita Gandhi; Mahamadou A Thera; Drissa Coulibaly; Karim Traoré; Ando B Guindo; Amed Ouattara; Shannon Takala-Harrison; Andrea A Berry; Ogobara K Doumbo; Christopher V Plowe
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.